RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in RVL Pharmaceuticals plc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +6 vs. Q4 2022
- Shares held
- 25.2M
- +149.7K (+0.6%) vs. Q4 2022
- Total value
- $28.7M
- +$789.8K (+2.8%) vs. Q4 2022
- New holders
- 8
- 3 more added
- Sold out
- 2
- 10 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVLP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $613 |
| Q3 2023 | 32 | $1.57M |
| Q2 2023 | 36 | $13.5M |
| Q1 2023 | 41 | $28.7M |
| Q4 2022 | 36 | $28.0M |
| Q3 2022 | 46 | $50.5M |
| Q2 2022 | 38 | $22.2M |
| Q1 2022 | 36 | $27.8M |
| Q4 2021 | 31 | $18.7M |
| Q3 2021 | 35 | $11.9M |
| Q2 2021 | 46 | $14.5M |
| Q1 2021 | 55 | $25.7M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding RVL Pharmaceuticals plc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Athyrium Capital Management, LP | 14,600,444 | $16.6M | 5.96% | 00.0% | Unchanged |
| Rovida Advisors Inc. | 3,000,000 | $3.42M | 1.33% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 1,623,000 | $1.85M | 0.02% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 1,256,393 | $1.43M | 0.53% | −545,471−30.3% | Reduced |
| Morgan Stanley | 1,057,558 | $1.21M | 0.00% | −39,075−3.6% | Reduced |
| Renaissance Technologies LLC | 697,415 | $795.0K | 0.00% | −17,800−2.5% | Reduced |
| Scoggin Management LP | 500,000 | $570.0K | 0.83% | +500,000 | New |
| Worth Venture Partners, LLC | 322,829 | $368.0K | 0.18% | −133,131−29.2% | Reduced |
| Geode Capital Management, LLC | 307,266 | $350.3K | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 276,428 | $315.1K | 0.01% | +276,428 | New |
| Vanguard Group Inc | 246,353 | $280.8K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 213,537 | $243.4K | 0.00% | +10,895+5.4% | Added |
| Millennium Management LLC | 160,411 | $183.0K | 0.00% | −13,536−7.8% | Reduced |
| Susquehanna International Group, LLP | 127,853 | $145.8K | 0.00% | +6,947+5.7% | Added |
| Marietta Wealth Management, LLC | 120,000 | $136.8K | 0.03% | 00.0% | Unchanged |
| Titleist Asset Management, LLC | 105,003 | $119.7K | 0.03% | +105,003 | New |
| State Street Corp | 78,687 | $89.7K | 0.00% | 00.0% | Unchanged |
| Insight Advisors, LLC | 75,646 | $86.2K | 0.02% | +37,823+100.0% | Added |
| Northern Trust Corp | 72,899 | $83.1K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 72,664 | $82.9K | 0.00% | −23,487−24.4% | Reduced |
| Citadel Advisors LLC | 41,539 | $47.4K | 0.00% | −5,604−11.9% | Reduced |
| Bridgeway Capital Management, LLC | 31,500 | $35.9K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 29,519 | $33.7K | 0.00% | 00.0% | Unchanged |
| Atria Wealth Solutions, Inc. | 23,000 | $26.2K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 21,210 | $24.2K | 0.00% | +21,210 | New |
| Jane Street Group, LLC | 17,785 | $20.3K | 0.00% | +17,785 | New |
| Wells Fargo & Company | 15,226 | $17.4K | 0.00% | −1,497−9.0% | Reduced |
| Barclays PLC | 13,697 | $15.6K | 0.00% | −9,620−41.3% | Reduced |
| Charles Schwab Investment Management Inc | 13,322 | $15.2K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 12,078 | $13.8K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 11,299 | $12.9K | 0.00% | +11,299 | New |
| SFMG, LLC | 10,000 | $11.4K | 0.00% | 00.0% | Unchanged |
| Williams Jones Wealth Management, LLC. | 10,000 | $11.4K | 0.00% | 00.0% | Unchanged |
| Tower View Investment Management & Research LLC | 4,100 | $5.00K | 0.00% | 00.0% | Unchanged |
| Dakota Community Bank & Trust NA | 3,980 | $4.54K | 0.03% | +3,980 | New |
| Tower Research Capital LLC (TRC) | 2,645 | $3.00K | 0.00% | +2,645 | New |
| Bank of America Corp | 1,720 | $1.96K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,187 | $1.35K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 225 | $257 | 0.00% | −1,157−83.7% | Reduced |
| BNP Paribas Arbitrage, SA | 7 | $8 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −39,818−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −14,100−100.0% | Sold out |
| Titleist Asset Management, Ltd. | – | – | – | – | Not filed |